Vimarsana
Biggest News Aggregation in the World

Ramon Varcoe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ramon Varcoe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ramon Varcoe Today - Breaking & Trending Today

VESTECK, invited to present at the 16th Annual Greenberg Stent Summit, Boston, MA - Vimarsana News

VESTECK, invited to present at the 16th Annual Greenberg Stent Summit, Boston, MA

/PRNewswire/ -- The VESTECK, Inc. Chief Technology Officer, invited to present the "SUTURE-TIGHT"™ technology at the 16th Annual Greenberg Stent Summit,...

Absorbable scaffold beats angioplasty for lower-leg artery disease - Vimarsana News

Absorbable scaffold beats angioplasty for lower-leg artery disease

In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15 - Vimarsana News

Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15

35-subject SWING Trial evaluates the safety, performance of Surmodics’ Sundance™ Sirolimus Drug-Coated Balloon Updated safety and performance data for the SWING trial 24-month data will be...

Resorbable Scaffold Beats Angioplasty in Below-Knee CLTI - Vimarsana News

Resorbable Scaffold Beats Angioplasty in Below-Knee CLTI

A drug-eluting resorbable scaffold was superior to angioplasty in treating infrapopliteal artery disease and chronic limb-threating ischemia and was noninferior for safety in the LIFE-BTK trial.

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI - Vimarsana News

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

(UPDATED) Going beyond angioplasty to achieve long-term gains challenges current thinking in BTK treatment, says Eric Secemsky.

Source: tctmd.com